CN102895446B - 一种治疗犬弓型虫病的中药组合物 - Google Patents
一种治疗犬弓型虫病的中药组合物 Download PDFInfo
- Publication number
- CN102895446B CN102895446B CN201210424686.8A CN201210424686A CN102895446B CN 102895446 B CN102895446 B CN 102895446B CN 201210424686 A CN201210424686 A CN 201210424686A CN 102895446 B CN102895446 B CN 102895446B
- Authority
- CN
- China
- Prior art keywords
- parts
- dog
- effects
- radix
- artemisia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 16
- 238000011282 treatment Methods 0.000 title abstract description 15
- 201000010099 disease Diseases 0.000 title abstract description 13
- 241000244030 Toxocara canis Species 0.000 title abstract 4
- 239000003814 drug Substances 0.000 claims description 25
- 210000000582 semen Anatomy 0.000 claims description 10
- 208000030852 Parasitic disease Diseases 0.000 claims description 6
- 241000221033 Quisqualis Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 244000080767 Areca catechu Species 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 206010037660 Pyrexia Diseases 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 206010012735 Diarrhoea Diseases 0.000 abstract description 2
- 206010023126 Jaundice Diseases 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 235000006226 Areca catechu Nutrition 0.000 abstract 3
- 235000003826 Artemisia Nutrition 0.000 abstract 2
- 241000049464 Artemisia apiacea Species 0.000 abstract 2
- 241001435059 Artemisia argyi Species 0.000 abstract 2
- 235000010894 Artemisia argyi Nutrition 0.000 abstract 2
- 235000011570 Artemisia caruifolia var apiacea Nutrition 0.000 abstract 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 2
- 241001643730 Hydrangea sect. Dichroa Species 0.000 abstract 2
- 240000004980 Rheum officinale Species 0.000 abstract 2
- 235000008081 Rheum officinale Nutrition 0.000 abstract 2
- 244000030166 artemisia Species 0.000 abstract 2
- 235000009052 artemisia Nutrition 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 76
- 241000282326 Felis catus Species 0.000 description 31
- 201000005485 Toxoplasmosis Diseases 0.000 description 21
- 208000024891 symptom Diseases 0.000 description 21
- 241000223996 Toxoplasma Species 0.000 description 18
- 235000013372 meat Nutrition 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000017074 necrotic cell death Effects 0.000 description 9
- 210000001165 lymph node Anatomy 0.000 description 8
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000003812 trophozoite Anatomy 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 238000000386 microscopy Methods 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 244000044425 Quisqualis indica Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- 238000003771 laboratory diagnosis Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000223997 Toxoplasma gondii Species 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 210000000059 tachyzoite Anatomy 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 208000000655 Distemper Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 208000014058 canine distemper Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 230000035931 haemagglutination Effects 0.000 description 4
- 230000002008 hemorrhagic effect Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 244000061458 Solanum melongena Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000000061 bradyzoite Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- LTGPFZWZZNUIIK-LURJTMIESA-N Lysol Chemical compound NCCCC[C@H](N)CO LTGPFZWZZNUIIK-LURJTMIESA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000016285 Movement disease Diseases 0.000 description 2
- 241000718543 Ormosia krugii Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 2
- 206010036600 Premature labour Diseases 0.000 description 2
- 206010041660 Splenomegaly Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000002555 auscultation Methods 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000001842 enterocyte Anatomy 0.000 description 2
- 210000003194 forelimb Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000007235 immunity generation Effects 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000026440 premature labor Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000004441 taeniasis Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- LJKULGMMXFJKPX-UHFFFAOYSA-N 1,2,2,3,4,4-hexamethoxypyrimidine Chemical compound COC1(N(C(N(C=C1)OC)(OC)OC)OC)OC LJKULGMMXFJKPX-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 241000647439 Artemisia ordosica Species 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000712083 Canine morbillivirus Species 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 208000002021 Enophthalmos Diseases 0.000 description 1
- 206010059410 Faecaluria Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004467 Infectious Canine Hepatitis Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241001501970 Prionailurus bengalensis Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000224003 Sarcocystis Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000002718 aborted fetus Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000973 gametocyte Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000001563 schizont Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000002025 tabes dorsalis Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210424686.8A CN102895446B (zh) | 2012-10-30 | 2012-10-30 | 一种治疗犬弓型虫病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210424686.8A CN102895446B (zh) | 2012-10-30 | 2012-10-30 | 一种治疗犬弓型虫病的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102895446A CN102895446A (zh) | 2013-01-30 |
CN102895446B true CN102895446B (zh) | 2014-08-13 |
Family
ID=47568132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210424686.8A Expired - Fee Related CN102895446B (zh) | 2012-10-30 | 2012-10-30 | 一种治疗犬弓型虫病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102895446B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129994A (zh) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | 一种治疗黄疸的中药组合物 |
CN101732426A (zh) * | 2010-02-10 | 2010-06-16 | 孙胜俊 | 一种猪高热病药物的组配及使用方法 |
CN101744932A (zh) * | 2008-12-15 | 2010-06-23 | 天津中敖生物科技有限公司 | 防治家禽球虫病的中药组合物 |
CN102579697A (zh) * | 2012-03-27 | 2012-07-18 | 贵州省畜牧兽医研究所 | 一种治疗鸡球虫病中草药制剂 |
CN102657764A (zh) * | 2012-06-01 | 2012-09-12 | 天津生机集团股份有限公司 | 一种用于防治鸡球虫病的中药散剂及其制备方法 |
-
2012
- 2012-10-30 CN CN201210424686.8A patent/CN102895446B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129994A (zh) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | 一种治疗黄疸的中药组合物 |
CN101744932A (zh) * | 2008-12-15 | 2010-06-23 | 天津中敖生物科技有限公司 | 防治家禽球虫病的中药组合物 |
CN101732426A (zh) * | 2010-02-10 | 2010-06-16 | 孙胜俊 | 一种猪高热病药物的组配及使用方法 |
CN102579697A (zh) * | 2012-03-27 | 2012-07-18 | 贵州省畜牧兽医研究所 | 一种治疗鸡球虫病中草药制剂 |
CN102657764A (zh) * | 2012-06-01 | 2012-09-12 | 天津生机集团股份有限公司 | 一种用于防治鸡球虫病的中药散剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102895446A (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104012798B (zh) | 用于治疗母猪子宫内膜炎的饲料、中药组合物及制备方法 | |
CN104256168B (zh) | 一种猪功能性饲料及其制备方法 | |
CN103006792A (zh) | 一种防治畜禽肠道疾病的中兽药及其制备方法与饲料 | |
CN102145111A (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
CN103719609B (zh) | 一种哺乳期母猪饲料及其制备方法 | |
CN102526302A (zh) | 一种抑制仔猪细菌性痢疾的中药微生态制剂及其制备方法 | |
CN101314004B (zh) | 一种治疗妇科泌尿系统感染的药物及其制备方法 | |
CN102846864B (zh) | 一种防治猪传染性萎缩性鼻炎的中药兽药及其制备方法 | |
CN104256165A (zh) | 用于防治慢性型猪瘟疫的功能性饲料及其制备方法 | |
CN103860616A (zh) | 刺五加提取物及其制备与应用 | |
Wali et al. | Intestinal obstruction by Ascaris lumbricoides in a 12-year-old boy: a case report in Pakistan | |
CN104258139A (zh) | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 | |
CN101816663B (zh) | 治疗家畜弓形虫病的药物组合物、注射液及其制备方法 | |
CN103652490B (zh) | 用于治疗猪蓝耳病的猪饲料及其制备方法 | |
CN102895446B (zh) | 一种治疗犬弓型虫病的中药组合物 | |
CN104274511A (zh) | 一种兽用中药组合物及其应用 | |
CN106234803A (zh) | 用于治疗仔猪白痢的饲料 | |
CN102327521B (zh) | 一种治疗老年肺炎的中药组合物、免煎颗粒剂及其制备方法 | |
CN105053741A (zh) | 防治猪繁殖与呼吸综合征的饲料 | |
CN102309643A (zh) | 一种用于治疗鸡球虫病的中药组合物 | |
Cui et al. | An outbreak of paragonimiosis in Zhengzhou city, China | |
CN112514850A (zh) | 一种香河狸的驯养方法 | |
CN103919983A (zh) | 防治畜禽上呼吸道感染的抗病毒、抑细菌合剂及方法 | |
CN109620877A (zh) | 纯中药禽用抗细菌病制剂及其制备方法和使用方法 | |
CN101066410B (zh) | 用于治疗妇科慢性盆腔炎的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN BIJIA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TIANJIN JIHE TECHNOLOGY CO., LTD. Effective date: 20140611 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Pei Yi Inventor after: Yuan Junying Inventor after: Yao Ruili Inventor after: Ju Boyan Inventor after: Li Fanfan Inventor after: Wang Xiangang Inventor after: Zheng Aibin Inventor after: Liu Yongkang Inventor after: Fan Peisong Inventor before: Pei Yi Inventor before: Wang Hongjie Inventor before: Liu Zhihui Inventor before: Su Yongpeng Inventor before: Huang Jian |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300383 XIQING, TIANJIN TO: 300380 XIQING, TIANJIN Free format text: CORRECT: INVENTOR; FROM: PEI YI WANG HONGJIE LIU ZHIHUI SU YONGPENG HUANG JIAN TO: PEI YI YUAN JUNYING YAO RUILI JU BOYAN LI FANFAN WANG XIANGANG ZHENG AIBIN LIU YONGKANG FAN PEISONG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140611 Address after: 300380 Tianjin city Xiqing district and Industrial Park Taihua Road No. 38 Applicant after: Tianjin Bijia Pharmaceutical Co., Ltd. Address before: East Wang Wen Zhen 300383 Tianjin District of Xiqing city government Applicant before: Tianjin Jihe Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medical composition for treatment of toxocara canis diseasees Effective date of registration: 20150113 Granted publication date: 20140813 Pledgee: China Co truction Bank Corp Tianjin Hexi sub branch Pledgor: Tianjin Bijia Pharmaceutical Co., Ltd. Registration number: 2015120000006 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140813 Termination date: 20201030 |